Multiple sclerosis and inflammatory bowel diseases: a systematic review and meta-analysis

Journal of Neurology

Volumn 264, Issue 2, 2017, Pages 254-259

  Kosmidou, Maria ^a   Katsanos, Aristeidis H ^a   Katsanos, Konstantinos H ^a   Kyritsis, Athanassios P ^a,b   Tsivgoulis, Georgios ^c,d   Christodoulou, Dimitrios ^a   Giannopoulos, Sotirios ^a,b  

^a UNIVERSITY OF IOANNINA   (Greece)

^b UNIVERSITY OF IOANNINA   (Greece)

^c UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^d UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Co existence; Crohn s disease; Demyelination; Inflammatory bowel diseases; Multiple sclerosis; Ulcerative colitis

Indexed keywords

ARTICLE; COMORBIDITY; CROHN DISEASE; DEMYELINATION; DISEASE ASSOCIATION; HUMAN; INFLAMMATORY BOWEL DISEASE; MULTIPLE SCLEROSIS; NEUROLOGIC EXAMINATION; PRIORITY JOURNAL; SYSTEMATIC REVIEW; ULCERATIVE COLITIS; COMPLICATION; INFLAMMATORY BOWEL DISEASES; META ANALYSIS;

COMORBIDITY; HUMANS; INFLAMMATORY BOWEL DISEASES; MULTIPLE SCLEROSIS;

EID: 84996479885     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-016-8340-8     Document Type: Article

References (26)

1. Zois CD, Katsanos KH, Kosmidou M, Tsianos EV (2010) Neurologic manifestations in inflammatory bowel diseases: current knowledge and novel insights. J Crohns Colitis 4:115–124
2. Katsanos AH, Kosmidou M, Giannopoulos S et al (2014) Cerebral arterial infarction in inflammatory bowel diseases. Eur J Intern Med 25:37–44
3. Katsanos AH, Katsanos KH, Kosmidou M, Giannopoulos S, Kyritsis AP, Tsianos EV (2013) Cerebral sinus venous thrombosis in inflammatory bowel diseases. Q J Med 106:401–413
4. Katsanos AH, Katsanos KH (2014) Inflammatory bowel disease and demyelination: more than just a coincidence? Expert Rev Clin Immunol 10:363–373
5. Pokorny CS, Beran RG, Pokorny MJ (2007) Association between ulcerative colitis and multiple sclerosis. Intern Med J 37:721–724
6. Lin CH, Kadakia S, Frieri M (2014) New insights into an autoimmune mechanism, pharmacological treatment and relationship between multiple sclerosis and inflammatory bowel disease. Autoimmun Rev 13:114–116
7. Alkhawajah MM, Caminero AB, Freeman HJ, Oger JJ (2013) Multiple sclerosis and inflammatory bowel diseases: what we know and what we would need to know! Mult Scler 19:259–265
8. Singh S, Kumar N, Loftus EV Jr, Kane SV (2013) Neurologic complications in patients with inflammatory bowel disease: increasing relevance in the era of biologics. Inflamm Bowel Dis 19:864–872
9. Liberati A, Altman DG, Tetzlaff J et al (2009) The prisma statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol 62:e1–e34
10. Stroup DF, Berlin JA, Morton SC et al (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 283:2008–2012
11. Deeks JJ, Higgins JP, Altman DG (2014) Chapter 9: Analysing data and undertaking meta-analyses. Cochrane Handbook for Systematic Reviews of Interventions website. http://handbook.cochrane.org/chapter_9/9_analysing_data_and_undertaking_meta_analyses.htm. Updated March 2011. Accessed 4 Feb 2014
12. Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629–634
13. Bernstein CN, Wajda A, Blanchard JF (2015) The clustering of other chronic inflammatory diseases in inflammatory bowel disease: a population-based study. Gastroenterology 129:827–836
14. Card TR, Langan SM, Chu TP (2016) Extra-gastrointestinal manifestations of inflammatory bowel disease may be less common than previously reported. Dig Dis Sci doi:10.1007/s10620-016-4195-1 (Epub ahead of print)
15. Edwards LJ, Constantinescu CS (2004) A prospective study of conditions associated with multiple sclerosis in a cohort of 658 consecutive outpatients attending a multiple sclerosis clinic. Mult Scler 10:575–581
16. Gupta G, Gelfand JM, Lewis JD (2005) Increased risk for demyelinating diseases in patients with inflammatory bowel disease. Gastroenterology 129:819–826
17. Langer-Gould A, Albers KB, Van Den Eeden SK, Nelson LM (2010) Autoimmune diseases prior to the diagnosis of multiple sclerosis: a population-based case-control study. Mult Scler 16:855–856
18. Marrie RA, Yu BN, Leung S et al (2013) The utility of administrative data for surveillance of comorbidity in multiple sclerosis: a validation study. Neuroepidemiology 40:85–92
19. Marrie RA, Patten SB, Tremlett H, et al (2016) Sex differences in comorbidity at diagnosis of multiple sclerosis: a population-based study. Neurology. doi:10.1212/WNL.0000000000002564 (Epub ahead of print)
20. Ramagopalan SV, Dyment DA, Valdar W et al (2007) Autoimmune disease in families with multiple sclerosis: a population-based study. Lancet Neurol 6:604–610
21. Roshanisefat H, Bahmanyar S, Hillert J, Olsson T, Montgomery S (2012) Shared genetic factors may not explain the raised risk of comorbid inflammatory diseases in multiple sclerosis. Mult Scler 18:1430–1436
22. Tremlett HL, Evans J, Wiles CM, Luscombe DK (2002) Asthma and multiple sclerosis: an inverse association in a case-control general practice population. Q J Med 95:753–756
23. Marrie RA, Reider N, Cohen J et al (2015) A systematic review of the incidence and prevalence of autoimmune disease in multiple sclerosis. Mult Scler 21:282–293
24. Dobson R, Giovannoni G (2013) Autoimmune disease in people with multiple sclerosis and their relatives: a systematic review and meta-analysis. J Neurol 260:1272–1285
25. Polman CH, Reingold SC, Edan G et al (2005) Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”. Ann Neurol 58:840–846
26. Polman CH, Reingold SC, Banwell B et al (2011) Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 69:292–302